- Home
- /
- News
- /
- Target Identification/ Validation
- /
- May 2010
Target Identification/ Validation News for May 2010
Thermo Fisher Scientific is to provide novel protein research products to the Institute for Systems Biology, supporting a two-year project to map the human proteome that is expected to accelerate biomarker discovery and advance personalized medicine.
26 May, 2010
Scientists at the Karolinska Institutet have developed a DNA vaccine that restricts the supply of blood to tumours and slows the growth of breast cancer tumours in mice.
25 May, 2010
Scientists have revealed that a set of proteins act as the cell’s ‘nose’ to ‘sniff out’ molecules that trigger cell growth.
24 May, 2010
New research funded by hearing loss charity RNID has revealed that even if hearing recovers after noise damage, permanent tinnitus could still develop.
11 May, 2010
Gentronix’s specialized GreenScreen HC test aims to enable pharmaceutical companies to accurately test compounds for genotoxicity without disrupting simultaneous drug discovery processes.
10 May, 2010
MDM2, the negative regulator of the tumour suppressor p53, is a major cancer target, and extensive evidence has shown that small molecules antagonizing this protein–protein interaction might have therapeutic value in fighting cancer.
06 May, 2010